Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001506679 | SCV001711609 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002495776 | SCV002799257 | likely benign | Bone mineral density quantitative trait locus 1; Exudative vitreoretinopathy 4; Exudative vitreoretinopathy 1; Worth disease; Autosomal dominant osteopetrosis 1; Osteoporosis with pseudoglioma; Osteoporosis; Polycystic liver disease 4 with or without kidney cysts | 2021-12-15 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001729926 | SCV001979156 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001506679 | SCV001980103 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003948483 | SCV004773205 | likely benign | LRP5-related disorder | 2022-10-18 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |